| View |
|
DR-XY25291
|
Fluorometholone
|
Flulon
|
0.1% w/ v
|
Ophthalmic suspension
|
Corticosteroid / Anti-infective
|
Santen Pharmaceutical Co., Ltd.
|
Japan
|
Automatic Renewal
|
28 September 2022
|
29 November 2027
|
| View |
|
DR-XY25303
|
Rabeprazole Sodium
|
Pariet
|
20mg
|
Tablet
|
Proton Pump Inhibitor
|
Bushu Pharmaceuticals Ltd.
|
Japan
|
Renewal
|
25 July 2024
|
08 June 2030
|
| View |
|
DR-XY25304
|
Rabeprazole Sodium
|
Pariet
|
10mg
|
Tablet
|
Proton Pump Inhibitor
|
Bushu Pharmaceuticals Ltd.
|
Japan
|
Renewal
|
30 June 2024
|
08 June 2030
|
| View |
|
DR-XY25316
|
Calcium (as gluconate)
|
None
|
100 mg/mL (10% w/v) (equivalent to 137.50 mg Calcium-glucono-galacto-gluconate)
|
Solution For Injection (IV)
|
Electrolyte Solution
|
Harson Laboratories
|
India
|
Renewal
|
22 November 2023
|
14 June 2029
|
| View |
|
DR-XY25319
|
Ascorbic Acid
|
Mycee
|
100mg/Ml
|
Syrup (Oral Drops)
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
24 June 2024
|
14 June 2029
|
| View |
|
DR-XY25359
|
Finasteride
|
Propecia
|
1mg
|
Tablet
|
Testosterone-5-Alpha Reductase Inhibitors
|
AIAIC International Pharma, LLC
|
U.S.A.
|
Automatic Renewal
|
14 May 2023
|
21 May 2028
|
| View |
|
DR-XY25365
|
Hydroxyurea
|
Krabinex
|
500 mg
|
Capsule
|
Antineoplastic
|
Korea United Pharm. Inc.
|
Korea
|
Initial (Variation)
|
07 March 2024
|
07 March 2029
|
| View |
|
DR-XY25386
|
Dacarbazine
|
None
|
200 mg
|
Powder for Injection (I.V.)
|
-
|
Zydus Hospira Oncology Private Limited (ZHOPL)
|
India
|
-
|
30 June 2021
|
10 May 2026
|
| View |
|
DR-XY25408
|
Tropicamide + Phenylephrine Hydrochloride
|
Sanmyd-P
|
5mg/ 5mg per mL
|
Ophthalmic solution
|
Mydriatic Agent
|
Santen Pharmaceutical Co., Ltd.
|
Japan
|
Automatic Renewal
|
30 December 2021
|
23 March 2027
|
| View |
|
DR-XY25409
|
Sodium Hyaluronate
|
Hialid
|
1mg/ mL (0.1%)
|
Ophthalmic solution
|
Eye Moisturizer/ Lubricant
|
Santen Pharmaceutical Co., Ltd.
|
Japan
|
Automatic Renewal
|
10 November 2022
|
18 December 2027
|
| View |
|
DR-XY25417
|
Ganciclovir
|
Virgan
|
1.5mg/g
|
Ophthalmic Gel
|
Antiviral
|
Farmila-Thea Farmaceutici S.P.A.
|
France
|
Renewal
|
02 August 2024
|
13 October 2029
|
| View |
|
DR-XY25423
|
Doxurubicin Hydrochloride
|
Ebedoxo
|
50 mg/25 mL (2 mg/mL)
|
Solution For Injection (I.V./I.A./Intravesicular)
|
Antineoplastic
|
Ebew Pharma Ges. M.b.H. Nfg. KG
|
Austria
|
Renewal
|
07 February 2024
|
28 July 2029
|
| View |
|
DR-XY25424
|
Doxorubicin Hydrochloride
|
Ebedoxo
|
10 mg/5 mL (2 mg/mL)
|
Solution For Injection (I.V./I.A./Intravesicular)
|
Antineoplastic
|
Ebew Pharma Ges. M.b.H. Nfg. KG
|
Autria
|
Renewal
|
23 February 2024
|
28 July 2029
|
| View |
|
DR-XY25428
|
Gestodene + Ethinylestradiol
|
Meliane
|
75 mcg/20 mcg
|
Tablet
|
-
|
Delpharm Lille SAS
|
France
|
Automatic Renewal
|
04 May 2023
|
03 June 2028
|
| View |
DR-XY25441_PI_01.pdf
|
DR-XY25441
|
Paclitaxel
|
Anzatax
|
6mg/mL
|
Solution For IV Infusion
|
-
|
Hospira Australia Pty. Ltd.
|
Australia
|
Initial (Variation)
|
30 June 2022
|
22 March 2027
|
| View |
|
DR-XY25446
|
Isosorbide Mononitrate
|
Imdur Durules
|
30 mg
|
Film-Coated Tablet
|
-
|
Laboratorios Alcala Farma, S.L.
|
Spain
|
Initial (Variation)
|
18 October 2022
|
18 October 2027
|
| View |
|
DR-XY25463
|
Ambroxol Hydrochloride
|
Voxoll
|
30 mg
|
Tablet
|
Expectorant (Mucolytic)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
17 May 2024
|
17 August 2029
|
| View |
DR-XY25482_PI_01.pdf
|
DR-XY25482
|
Lercanidipine
|
Zanidip
|
10mg
|
Tablet
|
-
|
Recordati Industria Chimica e Farmaceutica S.p.A.
|
Italy
|
-
|
20 January 2020
|
15 December 2024
|
| View |
|
DR-XY25483
|
Cisplatin
|
Ebeplatin
|
50mg/100mL (0.5mg/mL)
|
Concentrate For IV Infusion
|
-
|
Fareva Unterach GmbH
|
Austria
|
Initial (Variation)
|
12 August 2022
|
12 August 2027
|
| View |
|
DR-XY25485
|
Cisplatin
|
Ebeplatin
|
0.5mg/mL (10mg/20mL)
|
Concentrate For IV Infusion
|
-
|
Fareva Unterach GmbH
|
Austria
|
Initial (Variation)
|
12 August 2022
|
12 August 2027
|